Page last updated: 2024-12-08

4-methylphenylalanine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-methylphenylalanine: RN given refers to cpd without isomeric designation; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID151513
CHEMBL ID1230319
SCHEMBL ID44872
MeSH IDM0184650

Synonyms (35)

Synonym
CHEMBL1230319
1991-87-3
l-4-methylphenylalanine
4-methylphenylalanine
(2s)-2-amino-3-(4-methylphenyl)propanoic acid
(s)-2-amino-3-p-tolylpropanoic acid
phenylalanine, 4-methyl-
7758-37-4
A814071
AKOS012010209
4-methyl-l-phenylalanine
h-phe(4-me)-oh
4-methy-l-phenylalanine
AM83427
SCHEMBL44872
(s)-2-amino-3-p-tolyl-propionic acid
(s)-4-methylphenylalanine
DQLHSFUMICQIMB-VIFPVBQESA-N
DTXSID20228249
p-methylphenylalanine
(s)-2-amino-3-(p-tolyl)propanoic acid
J-300418
l-4-me-phe-oh
M2743
AC-9926
(2s)-2-azaniumyl-3-(4-methylphenyl)propanoate
4-methyl-l-phe-oh
F12350
AS-14585
BCP11552
CS-0128883
l-phenylalanine, 4-methyl-
Q27454875
l-4-methyl phenylalanine
EN300-267467
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1398361Trans-stimulation of human LAT1 expressed in TREx HEK293 cells assessed as induction of [3H]-gabapentin efflux at 200 uM after 3 mins by scintillation counting analysis relative to L-phenylalanine2018Journal of medicinal chemistry, 08-23, Volume: 61, Issue:16
Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1).
AID1398360Cis-inhibition of human LAT1 expressed in TREx HEK293 cells at 200 uM assessed as inhibition of [3H]-gabapentin uptake at 200 uM preincubated for 3 mins at 37 degC followed by washing with choline buffer and measured after 3 hrs by scintillation counting 2018Journal of medicinal chemistry, 08-23, Volume: 61, Issue:16
Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1).
AID1303218Substrate activity at human LAT1 expressed in HEK cells assessed as efflux rate of [3H]-gabapentin at 200 uM after 5 to 180 secs by scintillation counting based trans-stimulation assay2016Bioorganic & medicinal chemistry letters, 06-01, Volume: 26, Issue:11
LAT-1 activity of meta-substituted phenylalanine and tyrosine analogs.
AID1303219Inhibition of human LAT1 expressed in HEK cells assessed as reduction in uptake of [3H]-gabapentin at 200 uM after 3 mins by scintillation counting based cis-inhibition assay2016Bioorganic & medicinal chemistry letters, 06-01, Volume: 26, Issue:11
LAT-1 activity of meta-substituted phenylalanine and tyrosine analogs.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (10.00)18.7374
1990's1 (10.00)18.2507
2000's3 (30.00)29.6817
2010's5 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.52 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (10.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]